In a report released yesterday, Stephen Baxter from Wells Fargo maintained a Hold rating on Cardinal Health (CAH – Research Report), with a ...

Morgan Stanley analyst Erin Wright maintained a Buy rating on Cardinal Health (CAH – Research Report) today and set a price target of $136.00.

Cardinal Health, Inc. CAH is scheduled to report fiscal second-quarter 2025 results on Jan. 30, before the opening bell. In ...

In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe ...

Cardinal Health gets downgraded to a hold, from my buy rating last February, agreeing with the Seeking Alpha quant system rating. While macro-level demand for medical supplies is expected to keep ...

Cardinal Health announced construction is underway on a new distribution center in Fort Worth, Texas, which will support its at-Home Solutions business, a medical supplies provider that serves more ...

Shares have been on the move with the stock up 12.7% over the past month. The stock hit a new 52-week high of $109.04 in the previous session. Merit Medical has gained 12.7% since the start of the ...

Jim Cramer in a latest program on CNBC reminded viewers about the Trump playbook in the story market and said that he never ...

you should consider Cardinal Health (CAH). This company, which is in the Zacks Medical - Dental Supplies industry, shows potential for another earnings beat. This prescription drug distributor has ...

The company said the new DC will support its at-Home Solutions business and improve the delivery of medical supplies to ...